Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

Technology Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > CONTACT CIRO FOR LIFTING TRADING BAN !!
View:
Post by MetzGER on Jun 30, 2024 2:09am

CONTACT CIRO FOR LIFTING TRADING BAN !!

Please all contact CIRO (Canadian Investment Regulatory organization)

Report to the CIRO that the trading halt of Replicel Must be canceled immediately. After RepliCels hair regeneration technology was commercialized of Shiseido Company Replicel is a very valuable Company Holding worldwide rights of this Technology in Europe, America, South America... 
Replicel has to be back on the Stock msrket
immediately

https://www.ciro.ca/contact-us

Complaints & Inquiries

Investors (clients or prospective clients of investment firms) and members of the public should direct all questions or complaintsto our dedicated Complaints and Inquiries team (in English or French). Contacting other CIRO departments directly could result in delays.

Comment by Ingiboy on Jul 02, 2024 11:12am
Metzger if enough shareholders contact the CIRO they will be forced to look into this takever proposal. Once they do I can't see how they won't recommend the trading halt be lifted. With this takeover proposal there obviously is some legal issues that are holding up the process. Possibly the onesided structure of it is being challenged by the legal teams that are reviewing it.
Replicel Life Sciences Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities